-+ 0.00%
-+ 0.00%
-+ 0.00%

OPTIMA TRIAL RESULTS TO BE PRESENTED AT ASCO PROVIDE NEW EVIDENCE SUPPORTING PROSIGNA-GUIDED CHEMOTHERAPY DECISIONS IN BREAST CANCER

Reuters·05/21/2026 22:00:00

Please log in to view news